In Other News · United States · Business

Biotechs buck a sluggish IPO market, but investors should tread warily

Source: CNBC

Summary

While a number of IPOs have been pulled or delayed in 2026, the biotech sector has bucked the trend, with 26 companies debuting in U.S. markets.

You'll be taken to www.cnbc.com

Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.